TOF
6
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (6)
Residual Neuromuscular Blockade and PACU Admission
Quality of Life in Operated Adult Patients With Tetralogy of Fallot and Correlation With Myocardial Strain Analysis by CMR
Pediatric Ventricle Function Assessment Study
Prognostic Value of NLR, TLR, and ALC in Predicting ToF Primary Repair Outcome
Sugammadex Dosing: Anaesthesiologist Clinical Perception Versus Quantitative Monitoring
Pharmacokinetics and Pharmacodynamics of Rocuronium in Closed-Loop Infusion System